Lymphocytes from lymph nodes at different distances from human melanoma vary in their capacity to inhibit/enhance tumor cell growth in vitro

Melanoma Research

Volumn 7, Issue SUPPL. 2, 1997, Pages

  Farzad, Zohreh ^a   McBride, William H ^b   Ogbechi, Henrietta ^a   Asnong Holthoff, Carine ^a   Morton, Donald L ^a   Cochran, Alistair J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Growth enhancement; Growth inhibition; Lymph node lymphocyte; Lymphocyte subset; Melanoma; Metastasis; Tumor growth

Indexed keywords

ARTICLE; CANCER IMMUNOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MELANOMA; METASTASIS; PRIORITY JOURNAL; TARGET CELL; TUMOR GROWTH;

EID: 0030828657     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199708001-00010     Document Type: Article

References (33)

1. Fisher B. Fisher HR. Studies concerning the regional lymph node in cancer. I. Initiation of immunity. Caner 1971; 27:1001-1004.
2. Flannery Yd, Chalmers PJ, Rolland JM. el al. Immune response to a syngeneic rat tumor: development ot regional lymphocyte anergy. Br J Cancer 1978; 28:118-122.
3. Barna BP, Deodhar SD. Immunological activity of regional lymph node in tumor bearing mice. Cancer Res 1979; 39:2711-2717.
4. Yoshida K. Tachibana T. Studies on lymphatic metastasis. I. Primary immunoregulalory role of regional lymph nodes in the establishment of lymphatic metastasis. J Natl Cancer Inst 1985; 75:1049-1058.
5. Schuller DE. Impact of metastasis on nodal immunoreactivity in head and neck cancer. Laryngoscope 1986: 96:1189-1192.
6. Hawiylko E. Tumor bearer T cells suppress BCG-potentiated antitumor responses. I. Requirement for their effect. Cell Immunol 1982; 66:121-138.
7. Barna BP, Deodhar SD, The activity of regional nodes in the evolution ol immune response to allogeneic and isogeneic tumors, Cancer Res 1975; 35:920-926.
8. Anderson TM, Wasylyshyn ML. Moy PM, et al. Local and regional immune function in cancer patients. In Occult Nodal Metastasis In Solid Carcinoma. Edited by Moloy PJ, Nicolson GL. New York: Praeger, 1987:49-59.
9. Schautz, SP, Poisson L. Natural killer cell response to regional lymph node metastasis. Arch Otolaryngol Head Neck Surg 1986; 112:545-551.
10. Mukherji B, Wilhelm SA, Guha A, et al. Regulation of cellular immune response against autologous human melanoma. J Immnnol 1986; 136:1888-1898.
11. Akiyoshi T, Koba F, Tsuji H. Activated killer cell activity in lymph nodes, J Clin Lab Immnnol 1987; 22:91-95.
12. Koba F, Akiyoshi T, Tsuji H. Depression of the generation of cell-mediated cytotoxicity in regional lymph nodes ol patients with gastric carcinoma. J Clin Lab 1987; 22:181-184.
13. Mickel RA, Kessler DJ, Taylor JMG, et al. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. Cancer Res 1988; 48:5017-5022.
14. Cochran AJ, Wen D-R. Farzad Z, et al. Immunosuppression by melanoma cells as a factor in the generation of rnetastatic disease. Anticancer Res 1989; 9:859-864.
15. Cochran AJ, Hoon DBS, Korn FL, et al. Effect of indomethacin on the immunocompetence of human tumor draining lymph-nodes. Fed Proc 1985; 44:965.
16. Cochran A, Pihl H, Wen D-R, et al. Zoned immunosuppression of lymph nodes draining malignant melanoma: histologie and immunohistologic studies. J Natl Cancer Inst 1987; 78:399-405.
17. Cochran AJ, Wen D-R, Hoon DBS, et al. Tumor proximate immune suppression of regional lymph nodes in patients with malignant melanoma. In Treatment of Metastasis. Edited by Hellmann K, Eccles SA. London: Taylor and Francis, 1985:69-72.
18. Hoon DBS, Korn EL, Cochran AJ. Variation in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res 1987; 47:1710-1744.
19. Hoon DBS, Bowker R, Cochran AJ. Suppressor cell activity in melanoma-draining lymph nodes. Cancer Res 1987; 47:1529-1533.
20. Morion DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
21. Farzad Z, Cochran AJ, McBride WH, et al. Lymphocyte subset al terations in nodes regional to human melanoma. Cancer Res 1990; 50:3585-3588.
22. Dougherty GJ, Allen CA, Hogg NM. Application of immunological techniques to the study of the tumour - host relationship. In Application of Immunological Methods in Biomedical Sciences. Edited by Weir DM. Oxford: Blackwell Scientific Publications. 1986:125.1-125.12.
23. McBride WH. Notes on the use of in vitro technique for the assessment of cellular reactivity against tumours. In Handbook of Experimental Immunology. Edited by Weir DM. Oxford: Blackwell Scientific Publications, 1978:36.1-36.14.
24. Mantovani A, Peri G, Polentarutti N, et al. Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumor. Int J Cancer 1979; 23:157-162.
25. Norbury KC. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations. Cancer Res 1977; 37:1408-1413.
26. Vose BM, Vanky F, Argov S et al. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes. Eur J Immnnol 1987; 7:753-757.
27. Golub SH, Niitsuma M, Kawate N, et al. NK activity of tumor infil trating and lymph node lymphocytes in human pulmonary tumors. In NK Cells and Other Natural Effector Cells. Edited by Herberman RB. London; Academic Press, 1982:1113-1118.
28. Mukherji B, Cuba A, Chakraborty NG, et al. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 1989; 169:1961-1976.
29. Chakraborty NG, Twardzik DR, Sivanandham M, et al. Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response. J Immunol 1990; 145:2359-2364.
30. Droller MJ, Lindgren JA, Claessen HE, el al. Production of prostoglandin E2 by bladder tumor cells in tissue culture and a possible mechanism of lymphocyte inhibition. Cell Immunol 1979; 47:261-273.
31. Hoon DBS, Irie RF, Cochran AJ. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2. Cell Immunol 1988; 111:410-419.
32. Bennicelli JL, Guerry D. Production of multiple cytokines by human melanomas. Exp Dermatol 1993; 2:186-90.
33. Mattei S, Colombo C, Melani A, et al. Expression of cytokine growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56:853-857.